LSLena Sagi-Dain

Lena Sagi-Dain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lena Sagi-Dain has a total of 264 co-authors. Here are the top co-authors by number of shared publications:

  • Idit Maya

    Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    28 shared publications
  • Shlomi Sagi

    The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Department of Obstetrics and Gynecology, Bnei Zion Medical Center, Haifa, Israel

    22 shared publications
  • Amihood Singer

    Community Genetics Public Health Services, Ministry of Health Jerusalem Israel

    20 shared publications
  • Lina Basel-Salmon

    Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Pediatric Genetics Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel; Felsenstein Medical Research Center, Rabin Medical Center, Petah Tikva, Israel

    12 shared publications
  • Amir Peleg

    The Human Genetic Institute Carmel Medical Center Haifa Israel

    11 shared publications
  • Sarit Kahana

    Recanati Genetics Institute, Beilinson Hospital, Rabin Medical Center, Petach Tikva, Israel

    11 shared publications

Latest Publications

  • Open Access

    “The war within”: psychological mediators of the relationship between cumulative stress exposure and self-reported changes in gynecological symptoms among women during wartime

    by Liat Helpman, Noga Shiffman, Yael Mayer, Lena Sagi-Dain, Rinat Gabbay-Benziv

    Stress, particularly when caused by extreme events such as exposure to war conflict, has been associated with numerous health issues, including psychiatric symptoms, such as posttraumatic stress sy...

  • Variation in the Genetic Workup of Polyhydramnios: An International and Inter‐Specialty Survey

    by Roni Zemet, Yuval Yaron, Lena Sagi‐Dain

    Objective: To evaluate international and interprofessional variability in the definition and genetic evaluation of polyhydramnios, and to identify factors influencing clinical decision‐making. Method: An international electronic survey was distributed to healthcare professionals, addressing definitions of polyhydramnios, criteria for recommending invasive diagnostic prenatal testing, and preferred genetic testing strategies. Responses were analyzed by geographic region and professional specialty. Results: A total of 154 clinicians from diverse regions completed the survey. Most defined polyhydramnios using absolute ultrasound values rather than percentiles. While 17.8% recommended invasive diagnostic testing for any pregnancy with polyhydramnios, 41.8% did so only when additional anomalies were present. Maternal‐fetal medicine specialists were less likely to recommend invasive diagnostic testing (e.g., amniocentesis), particularly for mild isolated cases, whereas geneticists and genetic counselors were more likely to recommend prenatal genetic testing. US‐based respondents were more likely to recommend only fetal chromosome analysis, whereas Israeli respondents tended to recommend advanced molecular diagnostics even in isolated cases. Conclusion: Substantial variability was noted in the genetic evaluation of polyhydramnios, driven by specialty and geographic factors. These findings highlight the absence of a consistent evidence base and underscore the need for studies defining diagnostic yield by clinical scenario and testing modality to inform evidence‐based decision‐making, while recognizing that practice patterns also reflect local resources and healthcare systems.

  • Genetics first approach: Expanding the utility of genetic testing by nongeneticist physicians

    by Rotem Greenberg, Noa Shefer Averbuch, Lena Sagi-Dain, Idit Maya, Noa Ruhrman Shahar, Nesia Kropach-Gilad, Dina Mark-Yagel, Ran D. Balicer, Shay Ben Shachar


  • Is There an Alternative “Advanced Maternal Age” Threshold for Recommendation of Invasive Prenatal Testing?

    by Idit Maya, Liat Salzer Sheelo, Dana Brabbing-Goldstein, Reut Matar, Sarit Kahana, Ifaat Agmon-Fishman, Cochava Klein, Merav Gurevitch, Lina Basel-Salmon, Lena Sagi-Dain


  • Lessons learned from BRCA1/2 screening in Israel: A cross‐sectional survey comparing experiences and communication

    by Rotem Greenberg, Moran Echar, Amihood Singer, Lena Sagi‐Dain

    This study aimed to evaluate the perceived quality of pre‐ and post‐test explanations given to women carrying BRCA1/2 variants, and to compare these outcomes between two cohorts: female BRCA1/2 carriers identified through self‐reported population‐based screening (the screening group), in comparison to self‐reported formal pre‐test genetic counseling due to personal or familial cancer history (genetic counseling group). This cross‐sectional survey of female BRCA1/2 carriers employed an anonymous questionnaire distributed through the “Good Genes – a support and information group for BRCA carriers” association from January to March 2023. Main evaluated outcomes included the perceived quality of pre‐ and post‐test explanations, first analyzed in the overall cohort, and then compared between the 110 respondents in the screening group, to 444 women in the counseling group. In the screening group, 45.5% rated the perceived quality of pre‐test explanations as unsatisfactory, compared to 27.4% in the genetic counseling group (p = 0.0005). In terms of result delivery, the screening group reported higher instances of inappropriate timing (61.8% vs. 40.3%, p < 0.0001), suboptimal mode of delivery (55.5% vs. 37.5%, p = 0.0008) and suboptimal perceived quality in post‐test explanations (51.4% vs. 33.9%, p = 0.0006), as well as elevated stress levels (74.3% vs. 64.3%, p = 0.043). In the screening group, 21.5% of the women reported that the results were communicated by phone, letter, or online notice, compared to 17.2% in the counseling group, a non‐statistically significant difference. A logistic regression model controlling for timing and mode of delivery showed that both timing (β = 0.46, p < 0.001) and mode of delivery (β = 0.39, p < 0.001) remained significant predictors of dissatisfaction of post‐test counseling. The findings of this survey underscore the pressing need for enhancements in pre‐test explanation, as well as the post‐test counseling for positive results, especially within the realm of BRCA screening.


  • The Value of ROH Metrics for Predicting Morbidity: Insights From a Large Cohort Analysis of Chromosomal Microarray

    by Lena Sagi‐Dain, Michal Levy, Reut Matar, Sarit Kahana, Ifaat Agmon‐Fishman, Cochava Klein, Merav Gurevitch, Lina Basel‐Salmon, Idit Maya

    This retrospective cohort study aimed to define the optimal Regions of Homozygosity (ROH) size cut‐offs for prediction of morbidity, based on 13 483 Chromosomal Microarray Analyses (CMA). Receiver operating characteristic (ROC) curves were generated, and area under the curve (AUC) was used to assess the predictive capability of total ROH percentage (TRPS), ROH number and ROH segment size in distinguishing between healthy (n=6,196) and affected (n=6,839) cohorts. The metrics were examined for telomeric and interstitial segments, distinct TRPS categories, and across different ancestral origins. ROH segments were identified in 13 035 samples (96.7%), encompassing 66 710 ROH segments. Significant differences in TRPS and ROH segment size were observed between healthy and affected cohorts (p=0.012 and p < 0.001, respectively). However, no clinically significant thresholds could be established based on ROC curves for TRPS and ROH number per sample, as well as for ROH size (AUC 0.64, 0.55, and 0.62, respectively, Figure 1). The same was noted for telomeric versus interstitial locations, various origins, and subcategories of TRPS. In conclusion, this study highlights the complexity of ROH interpretation and emphasizes the importance of tailored reporting strategies in clinical practice. Our findings underscore the need for context‐specific reporting guidelines and further research, particularly in consanguineous populations.

  • Prevalence and characteristics of mistreatment during childbirth in two Israeli hospitals

    by Keshet Korem, Inbal Shlomi Polachek, Sara Cohen Shabot, Reuven Kedar, Mordechai Bardicef, Shlomi Sagi, Lena Sagi-Dain


  • Dystrophinopathy patient data as a guide to interpretation of pregestational female population screening for DMD gene variants

    by Lena Sagi-Dain, Annemieke Aartsma-Rus, Moran Echar, Julia Grinshpun-Cohen, Amihood Singer

    Pregestational population screening of healthy females for copy number variants in DMD gene has raised numerous challenges regarding the interpretation and disclosure of these findings. Our objective was to analyze data from a local dystrophinopathy patient database, in comparison to population screening results. Utilizing the “Little steps” association registry for children with dystrophinopathy, we classified genetic findings (out-of-frame, in-frame, or difficult-to-predict) in 231 DMD and 90 BMD male patients. A comparison was made with a previously published cohort of 162 female carriers identified through population screening. Duplications classified as “difficult to predict” were absent in DMD/BMD patients, as opposed to 45.1% of women analyzed in the scope of population screening (p < 0.0001). While the distribution of deletions did not differ between the groups, significantly higher proportion of duplications initiated at the proximal hot spot in the DMD/BMD cohort (87.1%), vs. only 11.7% in women analyzed through population screening (p = 0.0038). Notably, duplications initiating in the dp427c promoter area were noted only in the latter cohort (n = 62). Local databases of dystrophinopathy patients can facilitate analysis and reporting of pregestational female population screening results. These conclusions facilitate future introductions of population screening genetic tests for diseases with variable presentation.


  • Open Access

    How time influences episiotomy utilization and obstetric anal sphincter injuries (OASIS)

    by Eiman Shalabna, Soaad Nassar, Ariel Zilberlicht, Benjamin Feiner, Lena Sagi-Dain

    Objectives: Obstetric anal sphincter injuries (OASIS) pose significant challenges for young women following childbirth. The association between mediolateral episiotomy and OASIS remains a subject of debate and uncertainty. This study seeks to fill this gap. Methods: This retrospective cohort study was performed using electronic database of obstetrics department at a tertiary medical center. All vaginal deliveries and vacuum-assisted deliveries at term, with a singleton live fetus at cephalic presentation between 2015 and 2021, were included. A comparison of the rates of mediolateral episiotomy and OASIS was conducted between the periods 2015–2017 and 2018–2021. Subgroup analysis was carried out based on parity and the mode of delivery. Results: Overall, the study included 18,202 women. Between 2015 and 2017, episiotomy was performed in 1,272 cases (17.5 %), compared to 1,241 cases (11.4 %) between 2018 and 2021 (p<0.0001). Conversely, a significant increase in OASIS was observed, rising from 0.3 % during 2015–2017 to 0.6 % during 2018–2021 (p=0.012). Multivariable analysis unveiled two factors significantly linked to OASIS: the temporal cohort studied, indicating an increasing trend in recent years, and the utilization of epidural analgesia, which exhibited a protective effect, while episiotomy was not associated with OASIS. Conclusions: Our findings indicate a marked decline in the utilization of episiotomy over the study period, accompanied by an increase in OASIS incidence. Nevertheless, our analysis found no statistically significant link between episiotomy use and OASIS incidence.